Asthma Drug Xolair Guards Against Severe Reactions in People With Food Allergies
MONDAY, Feb. 26, 2024 -- The asthma medication Xolair has proved its prowess against food allergies, with new research showing the medication substantially lowers the chances of severe reactions in patients.Data published Sunday... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 26, 2024 Category: General Medicine Source Type: news
Can You Recycle Medical Devices Like Insulin Pens, Inhalers and Covid Tests?
Inhalers, EpiPens, home tests for flu or Covid, mouth guards. They accumulate in our homes, and recycling methods and advice can be tricky to pin down. (Source: NYT Health)
Source: NYT Health - February 26, 2024 Category: Consumer Health News Authors: Ted Alcorn Tags: Recycling of Waste Materials Medical Devices Waste Materials and Disposal Drugs (Pharmaceuticals) Asthma Containers and Packaging Sustainable Living Greenhouse Gas Emissions Food and Drug Administration Environmental Conservation Departm Source Type: news
Childhood maltreatment and immune cell gene regulation during adolescence: transcriptomics highlight non-classical monocytes - Kuhlman KR, Cole SW, Tan EN, Swanson JA, Rao U.
Childhood maltreatment has been repeatedly linked to a higher incidence of health conditions with an underlying proinflammatory component, such as asthma, chronic obstructive pulmonary disease, stroke, and cardiovascular disease. Childhood maltreatment has... (Source: SafetyLit)
Source: SafetyLit - February 26, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news
Drug Drastically Reduces Children ’s Reactions to Traces of Food Allergens
Xolair cuts the risk of dangerous reactions after exposure to minute amounts of allergens, researchers reported. But children taking it still must avoid risky foods. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Peanuts Children and Childhood Research Drugs (Pharmaceuticals) Immune System Eggs Milk Clinical Trials American Academy of Allergy Asthma and Immunology New England Journal of Medicine Genentech Source Type: news
Asthma drug limits serious reactions to allergy-triggering foods, study says
A drug approved to treat allergic asthma and chronic hives can limit children ' s dangerous allergic responses to small amounts of allergy-triggering foods, a new study reveals. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 25, 2024 Category: Consumer Health News Source Type: news
An Asthma Drug Can Drastically Reduce Food Allergies
About 20 million people in the U.S.—including four million children—have food allergies. Now, there’s a new way to reduce their risk of severe allergic reactions. A study published in the New England Journal of Medicine reports that the drug omalizumab, or Xolair, allows people with food allergies to tolerate higher doses of allergenic foods before developing a reaction after an accidental exposure. It also leads to milder reactions if they are exposed.
[time-brightcove not-tgx=”true”]
The drug was originally approved more than two decades ago to treat allergic asthma. But because of this ...
Source: TIME: Health - February 25, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
NY AG Urges Stricter Asthma Drug Warnings Due to Children ’s Mental Health Risks
The New York attorney general on Thursday urged the Food and Drug Administration to “take immediate action” and renew alerts to doctors and patients about the dangerous effects of Singulair for children, saying that the current warnings about the drug’s psychiatric side effects were not…#singulair #letitiajames #fda (Source: Reuters: Health)
Source: Reuters: Health - February 23, 2024 Category: Consumer Health News Source Type: news
NY AG Urges Stricter Asthma Drug Warnings Due to Children ’s Mental Health Risks
The A.G., Letitia James, called on the F.D.A. to redouble efforts to alert doctors about potential side effects of Singulair and to consider discouraging use of the drug for children. (Source: NYT Health)
Source: NYT Health - February 22, 2024 Category: Consumer Health News Authors: Christina Jewett and Benjamin Mueller Tags: Children and Childhood Attorneys General Asthma Drugs (Pharmaceuticals) Allergies Food and Drug Administration New York Times James, Letitia your-feed-healthcare Source Type: news
Move to Electric Vehicles Could Prevent Millions of Child Asthma Attacks Each Year
WEDNESDAY, Feb. 21, 2024 -- If all cars and trucks sold in America were " zero emission " by 2040 and the country ' s electric grid was also powered by clean energy, nearly 2.8 million child asthma attacks would be prevented annually, a new report... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2024 Category: General Medicine Source Type: news
Parents Scrambling After Asthma Inhaler Flovent Removed From Market
WEDNESDAY, Feb. 21, 2024 -- A popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly prescribed drugs for childhood asthma, but... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2024 Category: General Medicine Source Type: news
Electric cars could boost kids' health, study finds
Millions of childhood asthma attacks would be avoided and hundreds of infant lives saved by 2050 if the U.S. transitioned entirely to electric vehicles (EVs) powered by renewable energy, according to new research from the American Lung Association (ALA). Why it matters: Children are especially…#ala #epa #departmentofenergy #willbarrett #haroldwimmer #reality (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2024 Category: Consumer Health News Source Type: news
Peninsula biotech halts 2 clinical trials, stock loses 70% of value
The company, focused on inflammatory diseases such as asthma and eczema, has lost close to a half-billion dollars since it started in 2015. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 20, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Groundbreaking Food Allergy Treatment Research to Be Unveiled at 2024 American Academy of Allergy, Asthma & amp; Immunology Annual Meeting
Media Advisory for Late Breaking Symposium at the 2024 AAAAI Annual Meeting MILWAUKEE, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Renowned allergist Dr. Robert A. Wood, MD FAAAAI, will present detailed findings from a Phase 3 clinical trial that will have significant impact in the world of food... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
